While longitudinal data does not yet exist to adequately examine the association between letrozole use for ovulatory infertility and hormone related cancer risk, letrozole is currently used as an adjuvant treatment for hormone receptor positive postmenopausal breast cancer [115] thus it could be hypothesized that it would likely decrease hormonal related cancer risk. The gene discussed is NR4A1; the disease is Infertility.